Boothbay Fund Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-33,519
Closed -$645K 2583
2026
Q1
$645K Buy
33,519
+11,644
+53% +$229K 0.01% 1196
2025
Q4
$414K Buy
21,875
+1,609
+8% +$29.8K 0.01% 1247
2025
Q3
$378K Buy
+20,266
New +$379K 0.01% 1323
2024
Q2
Sell
-64,838
Closed -$958K 1821
2024
Q1
$958K Sell
64,838
-19,959
-24% -$276K 0.02% 769
2023
Q4
$1.21M Buy
84,797
+43,006
+103% +$611K 0.03% 670
2023
Q3
$583K Sell
41,791
-89,381
-68% -$1.14M 0.01% 968
2023
Q2
$1.54M Buy
+131,172
New +$1.49M 0.03% 655
2022
Q4
Sell
-113,707
Closed -$1.49M 2395
2022
Q3
$1.49M Sell
113,707
-3,136
-3% -$46.3K 0.04% 704
2022
Q2
$1.63M Sell
116,843
-69,628
-37% -$931K 0.04% 625
2022
Q1
$2.78M Buy
+186,471
New +$2.55M 0.06% 433
2017
Q4
Sell
-20,696
Closed -$454K 807
2017
Q3
$454K Buy
+20,696
New +$468K 0.08% 282

Other funds holding SBRA

Boothbay Fund Management's SBRA Position: Q2 2026 in Review

Boothbay Fund Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 33,519 shares — an estimated $645K sold.

Boothbay Fund Management first reported a position in SBRA in Q3 2017 and held it in 11 quarters. The position peaked at $2.78M in Q1 2022. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Boothbay Fund Management reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 33,519 Sabra Healthcare REIT shares in Q2 2026, an estimated $645K.
  • Boothbay Fund Management first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 11 quarters.
  • Boothbay Fund Management's Sabra Healthcare REIT position peaked at $2.78M in Q1 2022.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.